Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Oncosec Medical (ONCS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer....

ONCS : 1.76 (+4.76%)
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer

SAN DIEGO , Dec. 5, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the promotion of Christopher...

ONCS : 1.76 (+4.76%)
OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse® Platform

OncoSec Medical Incorporated ("OncoSec" or the "Company") (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has added two patents to its broad patent portfolio....

ONCS : 1.76 (+4.76%)
OncoSec Receives $9.3 Million Warrant Exercise

SAN DIEGO , Nov. 13, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has...

ONCS : 1.76 (+4.76%)
OncoSec Receives $9.3 Million Warrant Exercise

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into entered into a Warrant Exercise Agreement...

ONCS : 1.76 (+4.76%)
Corporate News Blog - OncoSec Medical Reports Positive Updated Follow-Up Data from Phase-2 Trial of ImmunoPulse IL-12 in Combination with Pembrolizumab

Research Desk Line-up: Radius Health Post Earnings Coverage

RDUS : 29.62 (+0.14%)
ONCS : 1.76 (+4.76%)
2 Stocks That Should Be on Your Radar Now

CORAL GABLES, FL / ACCESSWIRE / November 9, 2017 / Lexington Biosciences, Inc. (LXGTF) is a medical device company that is focusing on measuring and monitoring the cardiovascular system. The company's...

LXGTF : 0.4635 (-1.32%)
ONCS : 1.76 (+4.76%)
OncoSec Announces Preclinical Data Demonstrating Multi-Gene Expression Platform for Delivery of Multiple Cancer Immunotherapies at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2017

OncoSec Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company developing DNA-based cancer immunotherapies, will present emerging data from its novel, multi-gene expression platform termed Polycistronic...

ONCS : 1.76 (+4.76%)
OncoSec Announces Positive Updated Long-Term Follow-Up Data from Phase 2 Trial of ImmunoPulse® IL-12 in Combination with Pembrolizumab Demonstrating a Progression Free Survival Rate (PFS) of 57% at 15 months in Predicted Anti-PD-1 Non-Responder Melanoma Patients

OncoSec Medical Incorporated ("OncoSec" or "Company") (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced positive updated long-term follow-up data from its...

ONCS : 1.76 (+4.76%)
OncoSec Appoints Daniel J. O'Connor as Chief Executive Officer to Lead Next Stage of Growth as a Fully Integrated Late Stage Development and Commercial Company

OncoSec Medical Incorporated ("OncoSec" or "Company") (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the appointment of Daniel J. O'Connor as CEO of...

ONCS : 1.76 (+4.76%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

PALM BEACH, Florida, November 7, 2017 /PRNewswire/ --

CARA : 13.16 (+3.46%)
CTXR : 4.88 (+4.83%)
ONCS : 1.76 (+4.76%)
TXMD : 6.69 (-1.62%)
VBLT : 6.90 (-0.72%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

Commitment to bring new drug developments to the market through highly regarded and respected clinical research and studies are of a continued result of ongoing collaborations with academic and medical...

CARA : 13.16 (+3.46%)
CTXR : 4.88 (+4.83%)
ONCS : 1.76 (+4.76%)
VBLT : 6.90 (-0.72%)
TXMD : 6.69 (-1.62%)
OnoSec Medical, FYE Financial Review, Analysts Target and Upcoming SITC Presentation

NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

ONCS : 1.76 (+4.76%)
Recent Analysis Shows OncoSec Medical, Synchrony, DaVita, Capital One, TransEnterix, and Hess Market Influences - Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OncoSec Medical Incorporated...

SYF : 36.64 (-1.93%)
HES : 44.10 (-2.88%)
ONCS : 1.76 (+4.76%)
COF : 94.72 (-1.55%)
DVA : 71.30 (+1.28%)
TRXC : 2.11 (+3.94%)
Market for Electrophysiology (EP) Medical Devices Continues to Grow due to Rise in Cardiovascular Diseases

PALM BEACH, Florida, November 2, 2017 /PRNewswire/ --

ABT : 55.06 (-1.15%)
VRML : 1.98 (+3.66%)
APTO : 1.72 (-4.44%)
BSGM : 1.3500 (-0.74%)
ONCS : 1.76 (+4.76%)
Market for Electrophysiology (EP) Medical Devices Continues to Grow due to Rise in Cardiovascular Diseases

According to Transparency Market Research, The global electrophysiology devices market was valued at USD $2,500 million in 2012 and is expected to reach USD $5,496.6 million by 2019, growing at a CAGR...

ABT : 55.06 (-1.15%)
VRML : 1.98 (+3.66%)
APTO : 1.72 (-4.44%)
BSGM : 1.3500 (-0.74%)
ONCS : 1.76 (+4.76%)
OncoSec Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017

SAN DIEGO , Oct. 25, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results...

ONCS : 1.76 (+4.76%)
OncoSec Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the fourth quarter and fiscal year ended...

ONCS : 1.76 (+4.76%)
OncoSec Announces $7.1 Million Registered Direct Offering Priced At-the-Market

SAN DIEGO , Oct. 23, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has...

ONCS : 1.76 (+4.76%)
OncoSec Announces $7.1 Million Registered Direct Offering Priced At-the-Market

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive purchase agreements with...

ONCS : 1.76 (+4.76%)

Van Meerten Stock Picks

5 Great Mid Caps
  Today you will find that I have varied a little bit from my usual search criteria.
KBH -0.19 , IPGP +0.08 , FSLR -0.43 , NVR +1.03 , TTWO +0.12
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 -0.04% ) this morning are little changed, down -0.02% , and European stocks are down -0.18% ahead of the conclusion of the 2-day FOMC meeting later today where the market expects the FOMC... Read More

Chart of the Day

Chart of the Day

Carter's (CRI) is the Barchart Chart of the Day.  The children's appareal company has a Trend Spotter buy signal, a Weighted Alpha of 35.22+ and gained 22.23% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures settled the Wednesday session with most contracts 3/4 to 1 1/4 cents higher. This morning’s EIA report showed ethanol production dropping 19,000 barrels per day from the previous week. That number was still robust at 1.089 million ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.